Search

Search bills, members, committees and pages...

Sign In

YOKO ROSENBAUM

PreviousNext

19 federal lobbying filings, 2023 to 2026.

YOKO ROSENBAUM is a registered lobbyist named on 19 federal lobbying filings, 2023 to 2026, reporting $840K across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 they have filed under, by filings.

RegistrantFilingsReported
THE KPM GROUP DC LLC12$840K
RARE DISEASE COMPANY COALITION7—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$180K
20255—$290K
20244$560K—
20238$280K—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy15
HCRHealth Issues5
TRDTrade (domestic/foreign)4
SCIScience/Technology3
BUDBudget/Appropriations2
MMMMedicare/Medicaid1
TAXTaxation/Internal Revenue Code1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act5
H.R. 1414Cameron’s Law4
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.3
H.R. 946ORPHAN Cures Act3
H.R. 1532Scientific EXPERT Act of 20251
H.R. 1762Forest Service Accountability Act1
H.R. 4758Homeowner Energy Freedom Act1
H.R. 7148Consolidated Appropriations Act, 20261
H.R. 7384Preventing Mass Casualties from Release of Hydrofluoric Acid at Refineries Act of 20261

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2026 second_quarter$70KJul 16, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2026 first_quarter$110KApr 20, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 fourth_quarter$70KJan 20, 2026
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 third_quarter$90KOct 16, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 second_quarter$70KJul 18, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 first_quarter$60KApr 21, 2025
RARE DISEASE COMPANY COALITIONRARE DISEASE COMPANY COALITION2025 first_quarter—Apr 18, 2025
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 fourth_quarter$160KJan 21, 2025
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 third_quarter$140KOct 21, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 second_quarter$130KJul 19, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2024 first_quarter$130KApr 19, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 fourth_quarter$60KJan 22, 2024
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 fourth_quarter$10KJan 22, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 third_quarter$60KOct 20, 2023
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 third_quarter$10KOct 20, 2023
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 second_quarter$60KJul 19, 2023
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 second_quarter$10KJul 19, 2023
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 first_quarter$60KApr 21, 2023
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 first_quarter$10KApr 21, 2023